titanium has been researched along with Triple Negative Breast Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Chen, Y; Dai, X; Dong, C; Feng, G; Guo, J; Huang, H; Jing, X; Lin, L; Sun, D; Xie, L; Yang, D; Zhang, M | 1 |
| Cheng, K; Cheng, Z; Jenkins, CH; Liu, Y; Sano, M; Vernekohl, D; Wei, C; Xing, L; Zhang, G; Zhang, Y; Zhang, Z; Zhao, W | 1 |
| Chen, J; Feng, E; He, X; Tian, Y; Zheng, T | 1 |
| Futsuhara, K; Hata, S; Inoue, K; Kimizuka, K; Kojima, M; Kuroda, T; Nagai, SE; Saito, T; Sakurai, T; Yamada, H; Yamazaki, Y | 1 |
| Fang, Y; Huang, Z; Jiao, Y; Wang, J; Wang, X; Yang, X; Zhang, Q | 1 |
5 other study(ies) available for titanium and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Single Atom-Doped Nanosonosensitizers for Mutually Optimized Sono/Chemo-Nanodynamic Therapy of Triple Negative Breast Cancer.
Topics: Humans; Reactive Oxygen Species; Titanium; Triple Negative Breast Neoplasms; Ultrasonic Therapy | 2023 |
Synergistically Enhancing the Therapeutic Effect of Radiation Therapy with Radiation Activatable and Reactive Oxygen Species-Releasing Nanostructures.
Topics: Animals; Apoptosis; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Female; Gold; Humans; Metal Nanoparticles; Mice, Nude; Neoplasm Transplantation; Polyethylene Glycols; Radiation-Sensitizing Agents; Reactive Oxygen Species; Tissue Distribution; Titanium; Triple Negative Breast Neoplasms | 2018 |
A novel ternary heterostructure with dramatic SERS activity for evaluation of PD-L1 expression at the single-cell level.
Topics: B7-H1 Antigen; Female; Ferric Compounds; Graphite; Humans; Immunoassay; Metal Nanoparticles; Models, Theoretical; Single-Cell Analysis; Spectrum Analysis, Raman; Titanium; Triple Negative Breast Neoplasms; Tumor Cells, Cultured | 2018 |
TS-1 add-on therapy in Japanese patients with triple-negative breast cancer after neoadjuvant or adjuvant chemotherapy: a feasibility study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Epirubicin; Feasibility Studies; Female; Follow-Up Studies; Humans; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Prognosis; Silicates; Survival Rate; Titanium; Triple Negative Breast Neoplasms | 2020 |
Quantitative phosphoproteomics reveals genistein as a modulator of cell cycle and DNA damage response pathways in triple-negative breast cancer cells.
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Proliferation; DNA Damage; DNA Replication; G2 Phase Cell Cycle Checkpoints; Genistein; Humans; Isoflavones; Phosphoproteins; Phosphorylation; Proteome; Signal Transduction; Titanium; Triple Negative Breast Neoplasms | 2016 |